文献速递母胎医学产科

无创产前检测随访信息与妊娠结局分析

[Analysis of follow-up information and pregnancy outcomes of cell free DNA prenatal screening].
PubMed 文献 · Zhonghua Fu Chan Ke Za Zhi · 2020-01-01

该研究纳入2011年8月至2017年12月在南京医科大学附属妇产医院行cf-DNA检测的43 615例孕妇,分析随访信息与妊娠结局,计算常见染色体三体的筛查效能。结果显示cf-DNA对21、18、13三体敏感度和特异度均极高,但部分高风险孕妇未行侵入性确诊,低风险不良结局者多缺遗传诊断。

要点

  • cf-DNA对21三体敏感度97.96%、特异度99.96%,阳性预测值90.57%。
  • 高风险孕妇中仅82.31%接受侵入性产前诊断,随访体系存在缺口。
  • 低风险随访中572例妊娠结局不良,仅确认4例假阴性。

核心结论

  • cf-DNA检测对常见染色体三体具有极高的敏感度和特异度,但临床实践中高风险者拒绝侵入性确诊及低风险不良结局者缺乏遗传诊断信息是当前随访的主要局限。

研究设计与样本

  • 回顾性队列研究,纳入2011年8月至2017年12月南京医科大学附属妇产医院43 615例cf-DNA检测孕妇,收集一般信息、检测结果、确诊结果及随访结局。

主要发现

  • 43 615例中检测失败44例(0.10%),常见染色体三体高风险314例(0.72%),低风险43 257例(99.28%)。
  • 高风险314例中277例完成随访,228例(82.31%)接受侵入性产前诊断。
  • 低风险43 257例中36 826例完成随访,572例(1.55%)妊娠结局不良,其中4例为cf-DNA假阴性。
  • 完成随访的37 103例中,21三体敏感度97.96%、特异度99.96%、阳性预测值90.57%、阴性预测值99.99%。
  • 18三体敏感度96.67%、特异度99.95%、阳性预测值63.04%、阴性预测值99.98%;13三体敏感度100.00%、特异度99.95%、阳性预测值17.39%、阴性预测值100.00%。

关键数值与推荐

  • 21三体敏感度97.96%、特异度99.96%、阳性预测值90.57%、阴性预测值99.99%。
  • 18三体敏感度96.67%、特异度99.95%、阳性预测值63.04%、阴性预测值99.98%。
  • 13三体敏感度100.00%、特异度99.95%、阳性预测值17.39%、阴性预测值100.00%。
  • 检测失败率0.10%(44/43 615),高风险率0.72%(314/43 571),低风险率99.28%(43 257/43 571)。

临床怎么用

  • cf-DNA可作为常见染色体三体的高效产前筛查工具,但需加强遗传咨询,强调高风险者应行侵入性产前诊断验证。
  • 对低风险孕妇应完善随访,不良妊娠结局者尽可能获取胎儿染色体核型信息以评估假阴性。

局限性

  • 随访率非100%(高风险88.21%、低风险85.13%),存在失访偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate the efficacy of cell free DNA (cf-DNA) screening in prenatal care by analyzing the follow-up information and pregnancy outcomes. Methods: All cf-DNA cases conducted in Women's Hospital of Nanjing Medical University from August 2011 to December 2017 were enrolled. The general information of the pregnancies, cf-DNA results, confirmatory testing results, and the follow-up results were collected. The pregnancy outcomes were analyzed in cases with low risk cf-DNA results as well as with high risk results for common trisomies, which were trisomy 21 (T21), trisomy 18 (T18), and trisomy 13 (T13). The sensitivity, specificity, positive predictive value and negative predictive value of cf-DNA screening were calculated. Results: (1) A total of 43 615 cf-DNA cases were involved, with 44 cases (0.10%, 44/43 615) test failure results, 314 cases (0.72%, 314/43 571) high risk results for common trisomies and 43 257 cases (99.27%, 43 257/43 571) low risk results. (2) Among 277 cases (88.21%, 277/314) high risk cases were successfully followed up, and 228 cases (82.31%, 228/277) underwent invasive confirmatory prenatal diagnosis. In the low risk results, 36 826 cases (85.13%, 36 826/43 257) were successfully followed up, and 572 (1.55%, 572/36 826) cases were found to have adverse pregnancy outcomes, among which 4 false negative cf-DNA results were confirmed. (3) In the 37 103 successfully followed up cf-DNA cases, the sensitivity for T21, T18, T13 were calculated as 97.96%, 96.67% and 100.00%, respectively; the specificity for T21, T18, T13 were calculated as 99.96%, 99.95% and 99.95%, respectively. The positive predictive value for T21, T18, T13 were calculated as 90.57%, 63.04% and 17.39%, respectively. The negative predictive value for T21, T18, T13 were calculated as 99.99%, 99.98% and 100.00%. Conclusions: Cf-DNA is effective in detecting common trisomies, with a high sensitivity and specificity. However, the follow-up information revealed several potential limitations in current clinical practice, such as a number of cases with high risk results rejected invasive confirmatory testing, as well as the genetic diagnostic results for most low risk cases with an adverse pregnancy outcome aren't obtained. Genetic counseling and the follow-up for all the cf-DNA cases should be emphasized in the future. 目的: 通过分析孕妇外周血游离DNA(cf-DNA)检测结果的随访资料及相关的妊娠结局,评估cf-DNA检测在产前筛查中的价值。 方法: 收集2011年8月至2017年12月于南京医科大学附属妇产医院进行cf-DNA检测的孕妇的临床资料,包括孕妇的一般情况、cf-DNA检测结果及随访结果。并分析cf-DNA检测结果为常见染色体三体(包括21三体、18三体、13三体)高风险和低风险孕妇的妊娠结局,评价cf-DNA检测的价值,包括敏感度、特异度及阳性预测值、阴性预测值。 结果: (1)本研究共纳入了43 615例行cf-DNA检测的孕妇,其中44例(0.10%,44/43 615)检测失败;检出结果为常见染色体三体高风险314例(0.72%,314/43 571),低风险43 257例(99.28%,43 257/43 571)。(2)cf-DNA检测结果为常见染色体三体高风险的314例孕妇中,277例(88.21%,277/314)完成随访,其中228例(82.31%,228/277)孕妇接受了侵入性产前诊断为低风险的43 257例孕妇中,36 826例(85.13%,36 826/43 257)完成随访,其中572例(1.55%,572/36 826)妊娠结局不良,包括4例为cf-DNA检测结果假阴性。(3)在完成随访的37 103例孕妇中,21三体、18三体、13三体的敏感度分别为97.96%、96.67%、100.00%,特异度分别为99.96%、99.95%、99.95%,阳性预测值分别为90.57%、63.04%、17.39%,阴性预测值分别为99.99%、99.98%和100.00%。 结论: cf-DNA检测在胎儿常见染色体三体的产前筛查中具有极高的敏感度和特异度,但仍有一定数量的cf-DNA检测结果为常见染色体三体高风险的孕妇拒绝行侵入性产前诊断以验证cf-DNA检测结果。常见染色体三体低风险的孕妇,因未行侵入性产前诊断,导致部分孕妇出现不良妊娠结局时,无法获得胎儿的染色体核型信息。.

来源:Zhonghua Fu Chan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Liang D, Lin Y, Li H, et al. [Analysis of follow-up information and pregnancy outcomes of cell free DNA prenatal screening]. Zhonghua Fu Chan Ke Za Zhi. 2020. PMID: 32146739. doi:10.3760/cma.j.issn.0529-567X.2020.02.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。